Insulet Q2 2024 Adj. EPS $0.55 Misses $0.56 Estimate, Sales $488.500M Beat $463.315M Estimate
Portfolio Pulse from Benzinga Newsdesk
Insulet (NASDAQ:PODD) reported Q2 2024 earnings per share (EPS) of $0.55, missing the analyst consensus estimate of $0.56 by 1.79%. However, the company reported quarterly sales of $488.5 million, beating the analyst consensus estimate of $463.315 million by 5.44%. This represents a 23.20% increase over sales of $396.5 million in the same period last year.
August 08, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Insulet's Q2 2024 earnings per share (EPS) of $0.55 missed the analyst consensus estimate of $0.56 by 1.79%. However, the company reported quarterly sales of $488.5 million, beating the analyst consensus estimate of $463.315 million by 5.44%. This represents a 23.20% increase over sales of $396.5 million in the same period last year.
While Insulet's EPS missed the estimate by a small margin, the significant beat in sales and the strong year-over-year growth in revenue are positive indicators. This suggests strong demand for the company's products, which could lead to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100